Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

KMTS - Kestra Medical Technologies, Ltd.... | Finranks

Home

/

KMTS

K

Kestra Medical Technologies, Ltd. (KMTS)

NMS – Real Time Price. Currency in USD

27.72

-0.18 (-0.65%)

Market open: Aug 12, 2026, 11:08 AM EDT

27.90

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

95M

60M

28M

8M

Cost of goods sold

-46M

-36M

-27M

-18M

Gross Profit

49M

24M

362K

-11M

Operating expenses (excl. COGS)

-184M

-131M

-85M

-70M

Operating Income

-135M

-106M

-85M

-80M

Non-operating income, total

3M

-7M

-9M

-4M

Pretax income

-131M

-114M

-94M

-84M

Equity in earnings

0

0

0

0

Taxes

-294K

-135K

-24K

-15K

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-132M

-114M

-94M

-84M

Discontinued operations

0

0

0

0

Net income

-132M

-114M

-94M

-84M

Dilution adjustment

0

0

0

0

Preferred dividends

0

12M

7M

2M

Name

2025

2024

2023

2022

Total assets

358M+21.2%

296M+485.1%

51M+21.0%

42M

Total current assets

222M

255M

15M

18M

Total non-current assets

136M

40M

36M

23M

Total liabilities

99M+9.4%

90M+9.1%

83M+44.7%

57M

Total current liabilities

50M

38M

33M

37M

Total non-current liabilities

48M

52M

50M

20M

Total equity

260M

205M

-32M

-15M

Total liabilities & shareholders' equities

358M

296M

51M

42M

Total debt

47M+5.6%

44M-1.9%

45M+15.4%

39M

Name

2025

2024

2023

2022

Cash from operating activities

-82M

-78M

-72M

-70M

Cash from investing activities

-203M

-6M

-12M

-15M

Cash from financing activities

147M

313M

78M

96M

Free cash flow

-117M-15.7%

-101M-19.4%

-85M+0.4%

-85M